Business Novo Nordisk CEO to Step Down Amid Obesity Drug Market StrugglesBy Gazet InternationalMay 16, 20250 Novo Nordisk announced Friday that CEO Lars Fruergaard Jorgensen will step down. This follows a sharp drop in the company’s share price due to increased competition… Read More